Axiom Real-Time Metrics | Biotech Hunter

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

442

By Phase

PHASE2: 1PHASE2/PHASE3: 1NA: 1

By Status

COMPLETED: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Today

NCT04943172

NCT04802408

NCT05657691

Hover over trial bars to see details

Recent Trials

NCT05657691Collaborator

Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)

PHASE2Completed

167 participants

Started: Nov 28, 2022 · Completed: Jul 1, 2024

NCT04802408Collaborator

SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial

PHASE2/PHASE3Recruiting

200 participants

Started: Oct 1, 2021 · Completed: May 30, 2026

NCT04943172Collaborator

The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

NAActive, not recruiting

75 participants

Started: Aug 27, 2021 · Completed: Mar 31, 2028